Literature DB >> 18661117

[Learning and memory in the pathogenesis of addiction].

C von der Goltz1, F Kiefer.   

Abstract

The persistance of addiction-associated cognitions and behavior is caused, in least part, by long-lasting drug-associated memories. Relapses, triggered by exposure to drug-associated cues, contribute considerably to the maintenance of addiction and are, even after drug-free periods for years, a major challenge in the treatment of addiction. An important advance in understanding the underlying pathophysiology derives from recent research results showing similarities between the process of drug addiction and physiological neural plasticity in learning and memory. In the focus of attention are basic mechanisms involving dopamine, glutamate, and their cellular and molecular targets leading to drug-induced synaptic alterations in the mesolimbic reward system. There is growing evidence from preclinical and clinical studies that specific treatments such as extinction training and cue-exposure therapy are effective. The challenge of future research is to determine which drug-induced adaptations are relevant to the pathophysiology of addiction and to generate more efficient therapies for extinction of addiction-associated cognitions and behavior.

Entities:  

Mesh:

Year:  2008        PMID: 18661117     DOI: 10.1007/s00115-008-2534-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  50 in total

Review 1.  Molecular basis of long-term plasticity underlying addiction.

Authors:  E J Nestler
Journal:  Nat Rev Neurosci       Date:  2001-02       Impact factor: 34.870

Review 2.  Function and regulation of CREB family transcription factors in the nervous system.

Authors:  Bonnie E Lonze; David D Ginty
Journal:  Neuron       Date:  2002-08-15       Impact factor: 17.173

Review 3.  Is there a common molecular pathway for addiction?

Authors:  Eric J Nestler
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

Review 4.  Addictive drugs as reinforcers: multiple partial actions on memory systems.

Authors:  N M White
Journal:  Addiction       Date:  1996-07       Impact factor: 6.526

Review 5.  A neural substrate of prediction and reward.

Authors:  W Schultz; P Dayan; P R Montague
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

Review 6.  The hippocampal-VTA loop: controlling the entry of information into long-term memory.

Authors:  John E Lisman; Anthony A Grace
Journal:  Neuron       Date:  2005-06-02       Impact factor: 17.173

7.  Regulation of gene expression and cocaine reward by CREB and DeltaFosB.

Authors:  Colleen A McClung; Eric J Nestler
Journal:  Nat Neurosci       Date:  2003-10-19       Impact factor: 24.884

8.  Critical role for ventral tegmental glutamate in preference for a cocaine-conditioned environment.

Authors:  Glenda C Harris; Gary Aston-Jones
Journal:  Neuropsychopharmacology       Date:  2003-01       Impact factor: 7.853

9.  Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse.

Authors:  Danielle L Graham; Scott Edwards; Ryan K Bachtell; Ralph J DiLeone; Maribel Rios; David W Self
Journal:  Nat Neurosci       Date:  2007-07-08       Impact factor: 24.884

10.  Differential control over cocaine-seeking behavior by nucleus accumbens core and shell.

Authors:  Rutsuko Ito; Trevor W Robbins; Barry J Everitt
Journal:  Nat Neurosci       Date:  2004-03-21       Impact factor: 24.884

View more
  3 in total

1.  [Molecular biological aspects of neuroplasticity: approaches for treating tinnitus and hearing disorders].

Authors:  B Mazurek; H Olze; H Haupt; B F Klapp; M Adli; J Gross; A J Szczepek
Journal:  HNO       Date:  2010-10       Impact factor: 1.284

2.  Addiction and self-determination: a phenomenological approach.

Authors:  Jann E Schlimme
Journal:  Theor Med Bioeth       Date:  2010-02

Review 3.  [What can addiction research contribute towards the understanding of obesity?].

Authors:  F Kiefer; M Grosshans
Journal:  Nervenarzt       Date:  2009-09       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.